Biomedicines (May 2024)

Quantifying Hemodynamic Cardiac Stress and Cardiomyocyte Injury in Normotensive and Hypertensive Acute Heart Failure

  • Nikola Kozhuharov,
  • Eleni Michou,
  • Desiree Wussler,
  • Maria Belkin,
  • Corinna Heinisch,
  • Johan Lassus,
  • Krista Siirilä-Waris,
  • Harjola Veli-Pekka,
  • Nisha Arenja,
  • Thenral Socrates,
  • Albina Nowak,
  • Samyut Shrestha,
  • Julie Valerie Willi,
  • Ivo Strebel,
  • Danielle M. Gualandro,
  • Katharina Rentsch,
  • Micha T. Maeder,
  • Thomas Münzel,
  • Mucio Tavares de Oliveira Junior,
  • Arnold von Eckardstein,
  • Tobias Breidthardt,
  • Christian Mueller

DOI
https://doi.org/10.3390/biomedicines12051099
Journal volume & issue
Vol. 12, no. 5
p. 1099

Abstract

Read online

Background: The characterization of the different pathophysiological mechanisms involved in normotensive versus hypertensive acute heart failure (AHF) might help to develop individualized treatments. Methods: The extent of hemodynamic cardiac stress and cardiomyocyte injury was quantified by measuring the B-type natriuretic peptide (BNP), N-terminal proBNP (NT-proBNP), and high-sensitivity cardiac troponin T (hs-cTnT) concentrations in 1152 patients presenting with centrally adjudicated AHF to the emergency department (ED) (derivation cohort). AHF was classified as normotensive with a systolic blood pressure (SBP) of 90–140 mmHg and hypertensive with SBP > 140 mmHg at presentation to the ED. Findings were externally validated in an independent AHF cohort (n = 324). Results: In the derivation cohort, with a median age of 79 years, 43% being women, 667 (58%) patients had normotensive and 485 (42%) patients hypertensive AHF. Hemodynamic cardiac stress, as quantified by the BNP and NT-proBNP, was significantly higher in normotensive as compared to hypertensive AHF [1105 (611–1956) versus 827 (448–1419) pg/mL, and 5890 (2959–12,162) versus 4068 (1986–8118) pg/mL, both p p p < 0.001). Normotensive patients with a high BNP, NT-proBNP, or hs-cTnT had the highest mortality. The findings were confirmed in the validation cohort. Conclusion: Biomarker profiling revealed a higher extent of hemodynamic stress and cardiomyocyte injury in patients with normotensive versus hypertensive AHF.

Keywords